MCID: BCT006
MIFTS: 27

Bacterial Conjunctivitis malady

Summaries for Bacterial Conjunctivitis

About this section
Sources:
32MalaCards
See all sources

Fully expand this MalaCard

Export this MalaCard
MalaCards: Bacterial Conjunctivitis, also known as purulent conjunctivitis, is related to conjunctivitis and acute conjunctivitis. An important gene associated with Bacterial Conjunctivitis is GLYATL1 (glycine-N-acyltransferase-like 1). The drugs ciprofloxacin and loteprednol etabonate have been mentioned in the context of this disorder. Affiliated tissues include eye and testes.

Aliases & Classifications for Bacterial Conjunctivitis

About this section
Sources:
8Disease Ontology, 10DISEASES, 60UMLS, 56SNOMED-CT, 34MeSH, 39NCIt
See all sources

Aliases & Descriptions:

bacterial conjunctivitis 8 10 60
purulent conjunctivitis 8


External Ids:

Disease Ontology8 DOID:9700
MeSH34 D003234
NCIt39 C53656

Related Diseases for Bacterial Conjunctivitis

About this section
Sources:
17GeneCards, 18GeneDecks
See all sources

Diseases in the Conjunctivitis family:

Acute Conjunctivitis bacterial conjunctivitis
Chronic Conjunctivitis

Diseases related to Bacterial Conjunctivitis via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show all 11)
idRelated DiseaseScoreTop Affiliating Genes
1conjunctivitis11.1
2acute conjunctivitis10.8
3keratitis10.3
4iridocyclitis10.1
5purpura10.1
6ophthalmomyiasis10.0
7trachoma10.0
8blepharoconjunctivitis10.0
9influenza10.0
10pneumonia10.0
11tuberculosis10.0LACTB, GLYATL1

Graphical network of diseases related to Bacterial Conjunctivitis:



Diseases related to bacterial conjunctivitis

Clinical Features for Bacterial Conjunctivitis

About this section

Drugs & Therapeutics for Bacterial Conjunctivitis

About this section
Sources:
5CenterWatch, 41NIH Clinical Center, 6ClinicalTrials, 60UMLS, 40NDF-RT
See all sources

Approved drugs:

Search CenterWatch for Bacterial Conjunctivitis

Drug clinical trials:

Search ClinicalTrials for Bacterial Conjunctivitis

Search NIH Clinical Center for Bacterial Conjunctivitis

Search CenterWatch for Bacterial Conjunctivitis

Inferred drug relations via UMLS60/NDF-RT40:

Genetic Tests for Bacterial Conjunctivitis

About this section

Anatomical Context for Bacterial Conjunctivitis

About this section
Sources:
32MalaCards
See all sources

MalaCards organs/tissues related to Bacterial Conjunctivitis:

32
Eye, Testes

Animal Models for Bacterial Conjunctivitis or affiliated genes

About this section

Publications for Bacterial Conjunctivitis

About this section
Sources:
50PubMed
See all sources

Articles related to Bacterial Conjunctivitis:

(show top 50)    (show all 153)
idTitleAuthorsYear
1
Identification of causative pathogens in eyes with bacterial conjunctivitis by bacterial cell count and microbiota analysis. (23246122)
2013
2
Besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis patients with Pseudomonas aeruginosa infections. (23233796)
2012
3
Microbiological etiology and susceptibility of bacterial conjunctivitis isolates from clinical trials with ophthalmic, twice-daily besifloxacin. (22644963)
2012
4
Bacterial conjunctivitis. (22348418)
2012
5
Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomes. (22034555)
2011
6
Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children. (21397770)
2011
7
Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: etiology of bacterial conjunctivitis and antibacterial susceptibility profile. (22034556)
2011
8
Besifloxacin ophthalmic suspension: emerging evidence of its therapeutic value in bacterial conjunctivitis. (23861618)
2011
9
Detection of bacterial and viral organisms from the conjunctiva of cats with conjunctivitis and upper respiratory tract disease. (20817584)
2010
10
Hospital-acquired conjunctivitis in a neonatal intensive care unit: Bacterial etiology and susceptibility patterns. (20392539)
2010
11
Bacterial conjunctivitis. (21188158)
2010
12
Identifying children at low risk for bacterial conjunctivitis. (20194260)
2010
13
Effectiveness, tolerability and safety of azithromycin 1% in DuraSite for acute bacterial conjunctivitis. (20517467)
2010
14
Bacterial conjunctivitis. (21718563)
2010
15
Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study. (19393842)
2009
16
Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States. (19939250)
2009
17
Besifloxacin ophthalmic suspension for bacterial conjunctivitis. (19927224)
2009
18
Clinical and microbiological efficacy of levofloxacin administered three times a day for the treatment of bacterial conjunctivitis. (19123142)
2009
19
Besifloxacin, a new ophthalmic fluoroquinolone for the treatment of bacterial conjunctivitis. (19743941)
2009
20
Acute bacterial conjunctivitis. (17970823)
2008
21
The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment. (18369536)
2008
22
Fluoroquinolones compared to 1% azithromycin in DuraSite for bacterial conjunctivitis. (19668414)
2008
23
Response to correspondence from Lichtenstein and Granet Re: Fluoroquinolones compared to 1% azithromycin in DuraSite for bacterial conjunctivitis. (19668415)
2008
24
Acute bacterial conjunctivitis--benefits versus risks with antibiotic treatment. (18233997)
2008
25
Non-gonococcal bacterial agents of conjunctivitis and their antibiotic susceptibility patterns in Ilorin, Nigeria. (18390064)
2007
26
Comment on "Clinical features of bacterial conjunctivitis in children". (17656612)
2007
27
A randomized trial assessing the clinical efficacy and microbial eradication of 1% azithromycin ophthalmic solution vs tobramycin in adult and pediatric subjects with bacterial conjunctivitis. (19668507)
2007
28
Antibiotics versus placebo for acute bacterial conjunctivitis. (16625540)
2006
29
Controlling contagious bacterial conjunctivitis. (16491721)
2006
30
Secondary bacterial keratitis associated with shield ulcer caused by vernal conjunctivitis. (17102679)
2006
31
A clinical comparison of two formulations of tobramycin 0.3% eyedrops in the treatment of acute bacterial conjunctivitis. (16167284)
2005
32
Topical antibiotics for acute bacterial conjunctivitis: Cochrane systematic review and meta-analysis update. (16378567)
2005
33
Bacterial conjunctivitis. (16620434)
2005
34
Preparation of in situ-forming ophthalmic gels of ciprofloxacin hydrochloride for the treatment of bacterial conjunctivitis: in vitro and in vivo studies. (12532390)
2003
35
Efficacy and safety of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in pediatric patients. (14566313)
2003
36
A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis. (12623805)
2003
37
Are topical antibiotics effective in treating bacterial conjunctivitis? (11674916)
2001
38
Antimicrobial sensitivity of Haemophilus influenzae isolates from bacterial conjunctivitis. (11677911)
2001
39
Eye disorders: bacterial conjunctivitis. (10986192)
2000
40
The evolution of antibiotic therapy for bacterial conjunctivitis and keratitis: 1970-2000. (11009318)
2000
41
Comparative evaluation of the short-term bactericidal potential of a steroid-antibiotic combination versus steroid in the treatment of chronic bacterial blepharitis and conjunctivitis. (8997575)
1996
42
Topical lomefloxacin twice daily compared with fucidic acid in acute bacterial conjunctivitis. (8828727)
1996
43
Efficacy of norfloxacin in bacterial conjunctivitis. (1821203)
1991
44
A review of bacterial keratitis and bacterial conjunctivitis. (1928269)
1991
45
Trimethoprim-polymyxin B for bacterial conjunctivitis. (2370842)
1990
46
Trimethoprim-polymyxin B sulphate ophthalmic ointment versus chloramphenicol ophthalmic ointment in the treatment of bacterial conjunctivitis--a review of four clinical studies. The Trimethoprim-Polymyxin B Sulphate Ophthalmic Ointment Study Group. (2540136)
1989
47
Trimethoprim-polymyxin ophthalmic solution versus chloramphenicol ophthalmic solution in the treatment of bacterial conjunctivitis. (6292957)
1982
48
Drugs for bacterial conjunctivitis. (958152)
1976
49
Shokeir AA: A study of acute bacterial conjunctivitis in Assiout. (5744656)
1968
50
Bacterial conjunctivitis caused by an eye ointment base used as a placebo in therapeutic trials. (13708090)
1961

Genetic Variations for Bacterial Conjunctivitis

About this section

Expression for genes affiliated with Bacterial Conjunctivitis

About this section
Sources:
1BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Bacterial Conjunctivitis

Search GEO for disease gene expression data for Bacterial Conjunctivitis.

Pathways for genes affiliated with Bacterial Conjunctivitis

About this section

Compounds for genes affiliated with Bacterial Conjunctivitis

About this section

GO Terms for genes affiliated with Bacterial Conjunctivitis

About this section
Sources:
16Gene Ontology
See all sources

Cellular components related to Bacterial Conjunctivitis according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1mitochondrionGO:0057399.1LACTB, GLYATL1

Products for genes affiliated with Bacterial Conjunctivitis

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Bacterial Conjunctivitis

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
34MeSH
35MESH via Orphanet
36MGI
39NCIt
40NDF-RT
43NINDS
44Novoseek
46OMIM
47OMIM via Orphanet
50PubMed
51QIAGEN
57SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet